SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-301005
Filing Date
2014-08-07
Accepted
2014-08-07 17:26:11
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d747014d10q.htm 10-Q 402302
2 EX-31.1 d747014dex311.htm EX-31.1 7705
3 EX-31.2 d747014dex312.htm EX-31.2 7695
4 EX-32.1 d747014dex321.htm EX-32.1 4713
  Complete submission text file 0001193125-14-301005.txt   3447012

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20140630.xml EX-101.INS 405006
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20140630.xsd EX-101.SCH 40872
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20140630_cal.xml EX-101.CAL 56730
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20140630_def.xml EX-101.DEF 85011
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20140630_lab.xml EX-101.LAB 297394
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20140630_pre.xml EX-101.PRE 211681
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 141024943
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences